The 6 analysts offering 1 year price forecasts for PHME have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to PHME in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
PHME EPS for the last quarter is 0.22 EUR despite the estimation of 0.21 EUR. In the next quarter EPS is expected to reach −0.37 EUR. Track more of PHARMA MAR SA financials and stay on top of what is up with the company.
In the next quarter PHARMA MAR SA revenue is expected to reach 34.80 M EUR. Check out PHARMA MAR SA revenue and earnings and make informed decisions.
According to analysts, PHME price target is 74.27 EUR with a max estimate of 95.00 EUR and a min estimate of 29.60 EUR. Check if this forecast comes true in a year, meanwhile watch PHARMA MAR SA stock price chart and keep track of the current situation with PHME news and stock market news.
We've gathered opinions of 6 analysts rating PHME stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.